Increasing the price of respiratory sprays several times; Warning about drug shortages

The price of respiratory sprays has faced a significant jump following the increase in drug costs and import restrictions; So, according to an expert, the cost of obtaining these drugs, which was much lower with insurance, has now reached several million tomans and has made it more difficult for patients to choose the right drug.

Ambassador of Arjan-Social Group: Alireza Kashfizadeh, on the sidelines of the 12th "National Congress of Lung Diseases, Special Care and Sleep" at the International Conference Center of Iran University of Medical Sciences, said: The variety of respiratory sprays is not as wide as before and we are facing restrictions on the import of this type of medicine.

With regard to the restrictions that have been created in the way of importing and supplying medicine, he added: "Unfortunately, we do not benefit from a variety of respiratory sprays in the current situation, and this has caused patients to face limitations in choosing their medicine."

Referring to the complications of respiratory sprays, Kashfizadeh said: When a patient develops a complication, we change his spray, but we must know that the complications of each respiratory spray are different.

The associate professor of Shahid Beheshti University of Medical Sciences, regarding the price of respiratory sprays after the increase in the price of drugs, said: Unfortunately, the prices of respiratory sprays have increased tremendously.

He continued: "The price of respiratory sprays has increased several dozen times, so that the patient used to pay 60,000 to 200,000 tomans with insurance, but now it has reached 1.5 to 5 million tomans."

By implementing a new mechanism, the Central Bank has made the transfer of large sums by the trustees conditional on the approval of the initial performance; The decision was taken with the aim of controlling currency violations and preventing disruptions in the supply of imported currency.

About 9 months have passed since the foreign currency demands of the private sector, the debt of 4.07 billion euros has not been settled and the order of the president three months ago has not been implemented.

The director general of food and beverage products of the Food and Drug Organization announced the design of new mechanisms to facilitate the supply and import of basic goods and said: "The green route will be created for qualified companies."